Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Diffusion Pharmaceuticals Inc
(NQ:
DFFN
)
0.8300
USD
-0.0511 (-5.80%)
Official Closing Price
/ Updated:
4:47 PM EDT, Jul 9, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
2,904,405
Open
0.8640
Bid (Size)
0.8302 (3)
Ask (Size)
0.8498 (4)
Prev. Close
0.8811
Today's Range
0.8003 - 0.8798
52wk Range
0.2110 - 2.720
Shares Outstanding
50,526,547
Dividend Yield
N/A
Performance
YTD
+79.93%
+79.93%
1 Month
-27.83%
-27.83%
3 Month
+110.23%
+110.23%
6 Month
+76.60%
+76.60%
1 Year
-61.78%
-61.78%
Top News
More News
Diffusion Pharmaceuticals Files IND for International Phase 1b/2b COVID-19 Clinical Program With TSC
July 07, 2020
from
GlobeNewswire News Releases
Diffusion Pharmaceuticals Files Clinical Trial Application for European Phase 1a/1b Study of TSC in COVID-19 Patients
June 11, 2020
Dosing expected to begin in Q2 2020 with first data in Q3 2020 Trial expected to enroll 224 patients over 12 months, with 24 patients immediately U.S. IND filing planned for later this month
Read More
from
GlobeNewswire News Releases
More News
Read More
Diffusion Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
June 01, 2020
from
GlobeNewswire News Releases
Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program
May 26, 2020
from
GlobeNewswire News Releases
Diffusion Pharmaceuticals Inc. Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market
May 20, 2020
from
GlobeNewswire News Releases
Diffusion Pharmaceuticals Expands Clinical Trial Program of TSC for the Treatment of COVID-19 Patients to Include the Romanian National Institute of Infectious Diseases
May 20, 2020
from
GlobeNewswire News Releases
Top Penny Stocks To Buy Right Now Under $2.50
May 23, 2020
from
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
May 18, 2020
from
GlobeNewswire News Releases
Diffusion Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
May 11, 2020
from
GlobeNewswire News Releases
What Are The Best Penny Stocks To Buy? 3 To Watch Right Now
May 12, 2020
from
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Thinking about buying stock in Unum Therapeutics, Diffusion Pharmaceuticals, Sunrun Inc, Delta Air Lines, or Hertz Global Holdings?
July 07, 2020
from
PR Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
